Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001069530-21-000045
Filing Date
2021-08-04
Accepted
2021-08-04 17:20:09
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sava-20210630x10q.htm   iXBRL 10-Q 1718972
2 EX-10.3 sava-20210630xex10_3.htm EX-10.3 599106
3 EX-31.1 sava-20210630xex31_1.htm EX-31.1 25614
4 EX-31.2 sava-20210630xex31_2.htm EX-31.2 25246
5 EX-32.1 sava-20210630xex32_1.htm EX-32.1 20495
6 GRAPHIC sava-20210630x10qg001.jpg GRAPHIC 45735
7 GRAPHIC sava-20210630x10qg002.jpg GRAPHIC 48837
8 GRAPHIC sava-20210630x10qg003.jpg GRAPHIC 46460
9 GRAPHIC sava-20210630x10qg004.jpg GRAPHIC 21931
10 GRAPHIC sava-20210630x10qg005.jpg GRAPHIC 122251
  Complete submission text file 0001069530-21-000045.txt   7313682

Data Files

Seq Description Document Type Size
11 EX-101.SCH sava-20210630.xsd EX-101.SCH 28741
12 EX-101.CAL sava-20210630_cal.xml EX-101.CAL 33099
13 EX-101.DEF sava-20210630_def.xml EX-101.DEF 88728
14 EX-101.LAB sava-20210630_lab.xml EX-101.LAB 223905
15 EX-101.PRE sava-20210630_pre.xml EX-101.PRE 198990
16 EXTRACTED XBRL INSTANCE DOCUMENT sava-20210630x10q_htm.xml XML 1259328
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 211145177
SIC: 2834 Pharmaceutical Preparations